Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity

Pharmacology. 1995 Jun;51(1):56-65. doi: 10.1159/000139317.

Abstract

The immunomodulatory potential of the indole alkaloids ibogaine and harmaline was examined in a panel of in vitro immune function assays. These assays were chosen to assess T-cell regulatory and effector function, B-cell function, macrophage function, and natural killer-cell function. The in vitro exposure to either ibogaine or harmaline resulted in a dose-related suppression of all immune functions examined except macrophage function. This suppression was noted at various concentrations in different assays, but was generally only associated with high concentrations (10-100 mumol/l).

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • B-Lymphocytes / drug effects
  • Female
  • Hallucinogens / pharmacology*
  • Harmaline / pharmacology*
  • Ibogaine / pharmacology*
  • In Vitro Techniques
  • Interleukin-6 / biosynthesis
  • Killer Cells, Natural / drug effects
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • T-Lymphocytes / drug effects

Substances

  • Adjuvants, Immunologic
  • Hallucinogens
  • Interleukin-6
  • Ibogaine
  • Harmaline